Literature DB >> 25436138

A patient with cholangiocarcinoma demonstrating pathologic complete response to chemotherapy: exploring the role of neoadjuvant therapy in biliary tract cancer.

Evan J Walker1, Jeffry P Simko1, Eric K Nakakura1, Andrew H Ko1.   

Abstract

The role of neoadjuvant chemotherapy and/or radiation for localized or potentially resectable cholangiocarcinoma (CCA) has not been well established. We present here the case of a patient with an extrahepatic CCA who achieved a pathologic complete response after undergoing preoperative gemcitabine-based chemotherapy, without sequential or concurrent use of radiation. Further evaluation of neoadjuvant strategies in CCA, including not only combined-modality therapy but also the use of chemotherapy exclusively, is warranted in prospective study design.

Entities:  

Keywords:  Cholangiocarcinoma (CCA); chemotherapy; complete response; neoadjuvant

Year:  2014        PMID： 25436138      PMCID： PMC4226816          DOI： 10.3978/j.issn.2078-6891.2014.051

Source DB:  PubMed          Journal:  J Gastrointest Oncol        ISSN： 2078-6891


  37 in total

1.  Can we cure cholangiocarcinoma with neoadjuvant chemoradiation and liver transplantation? Time for a multicenter trial.

Authors:  Robin K Kelley; Ryutaro Hirose; Alan P Venook
Journal:  Liver Transpl       Date:  2012-05       Impact factor: 5.799

2.  Surgical and palliative management and outcome in 184 patients with hilar cholangiocarcinoma: palliative photodynamic therapy plus stenting is comparable to r1/r2 resection.

Authors:  Helmut Witzigmann; Frieder Berr; Ulrike Ringel; Karel Caca; Dirk Uhlmann; Konrad Schoppmeyer; Andrea Tannapfel; Christian Wittekind; Joachim Mossner; Johann Hauss; Marcus Wiedmann
Journal:  Ann Surg       Date:  2006-08       Impact factor: 12.969

3.  Neoadjuvant chemoradiation for extrahepatic cholangiocarcinoma.

Authors:  K M McMasters; T M Tuttle; S D Leach; T Rich; K R Cleary; D B Evans; S A Curley
Journal:  Am J Surg       Date:  1997-12       Impact factor: 2.565

Review 4.  Recent advances in the management of cholangiocarcinomas.

Authors:  J N Vauthey; L H Blumgart
Journal:  Semin Liver Dis       Date:  1994-05       Impact factor: 6.115

5.  Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer.

Authors:  Juan Valle; Harpreet Wasan; Daniel H Palmer; David Cunningham; Alan Anthoney; Anthony Maraveyas; Srinivasan Madhusudan; Tim Iveson; Sharon Hughes; Stephen P Pereira; Michael Roughton; John Bridgewater
Journal:  N Engl J Med       Date:  2010-04-08       Impact factor: 91.245

6.  Efficacy of neoadjuvant chemoradiation, followed by liver transplantation, for perihilar cholangiocarcinoma at 12 US centers.

Authors:  Sarwa Darwish Murad; W Ray Kim; Denise M Harnois; David D Douglas; James Burton; Laura M Kulik; Jean F Botha; Joshua D Mezrich; William C Chapman; Jason J Schwartz; Johnny C Hong; Jean C Emond; Hoonbae Jeon; Charles B Rosen; Gregory J Gores; Julie K Heimbach
Journal:  Gastroenterology       Date:  2012-04-12       Impact factor: 22.682

7.  Phase I trial of neoadjuvant chemoradiation with gemcitabine and surgical resection for cholangiocarcinoma patients (NACRAC study).

Authors:  Yu Katayose; Toshiki Rikiyama; Fuyuhiko Motoi; Kuniharu Yamamoto; Hiroshi Yoshida; Takanori Morikawa; Hiroki Hayashi; Atsushi Kanno; Morihisa Hirota; Kennichi Satoh; Hisanori Ariga; Masaki Suzuki; Motoki Ohyauchi; Yutaka Kondo; Shinichi Ikeya; Yoshihiro Ogawa; Tooru Shimosegawa; Shinichi Egawa; Michiaki Unno
Journal:  Hepatogastroenterology       Date:  2011 Nov-Dec

8.  Yttrium-90 radioembolization for intrahepatic cholangiocarcinoma: safety, response, and survival analysis.

Authors:  Samdeep Mouli; Khairuddin Memon; Talia Baker; Al B Benson; Mary F Mulcahy; Ramona Gupta; Robert K Ryu; Riad Salem; Robert J Lewandowski
Journal:  J Vasc Interv Radiol       Date:  2013-04-19       Impact factor: 3.464

9.  Patterns of initial disease recurrence after resection of gallbladder carcinoma and hilar cholangiocarcinoma: implications for adjuvant therapeutic strategies.

Authors:  William R Jarnagin; Leyo Ruo; Sarah A Little; David Klimstra; Michael D'Angelica; Ronald P DeMatteo; Raquel Wagman; Leslie H Blumgart; Yuman Fong
Journal:  Cancer       Date:  2003-10-15       Impact factor: 6.860

10.  Gemcitabine alone or in combination with cisplatin in patients with biliary tract cancer: a comparative multicentre study in Japan.

Authors:  T Okusaka; K Nakachi; A Fukutomi; N Mizuno; S Ohkawa; A Funakoshi; M Nagino; S Kondo; S Nagaoka; J Funai; M Koshiji; Y Nambu; J Furuse; M Miyazaki; Y Nimura
Journal:  Br J Cancer       Date:  2010-07-13       Impact factor: 7.640
View more
  6 in total

1.  Locally Advanced Intrahepatic Cholangiocarcinoma: Complete Pathologic Response to Neoadjuvant Chemotherapy Followed by Left Hepatic Trisectionectomy and Caudate Lobectomy.

Authors:  Thuy B Tran; Chinmaya K Bal; Kurt Schaberg; Teri A Longacre; Bhupinder S Chatrath; George A Poultsides
Journal:  Dig Dis Sci       Date:  2015-04-01       Impact factor: 3.199

2.  Impact of adjuvant chemoradiation on survival in patients with resectable cholangiocarcinoma.

Authors:  Laura L Dover; Robert A Oster; Andrew M McDonald; Derek A DuBay; Thomas N Wang; Rojymon Jacob
Journal:  HPB (Oxford)       Date:  2016-08-16       Impact factor: 3.647

Review 3.  Technical Aspects of Gallbladder Cancer Surgery.

Authors:  Motaz Qadan; T Peter Kingham
Journal:  Surg Clin North Am       Date:  2016-04       Impact factor: 2.741

4.  A pathological complete response after combined chemotherapy of gemcitabine and S-1 in advanced biliary tract cancer with para-aortic lymph nodes metastasis: a case report.

Authors:  Takeshi Watanabe; Junji Furuse; Naohiro Okano; Yutaka Suzuki; Hiroshi Kamma; Masanori Sugiyama
Journal:  Surg Case Rep       Date:  2017-02-12

5.  The maximum chemiluminescence intensity predicts severe neutropenia in gemcitabine-treated patients with pancreatic or biliary tract cancer.

Authors:  Koki Goto; Ryusei Matsuyama; Yusuke Suwa; Sayaka Arisaka; Toshiaki Kadokura; Mari Sato; Ryutaro Mori; Takafumi Kumamoto; Masataka Taguri; Itaru Endo
Journal:  Cancer Chemother Pharmacol       Date:  2018-09-14       Impact factor: 3.333

6.  Pathological complete response achieved by gemcitabine plus cisplatin therapy for initially unresectable advanced gallbladder cancer: a case report.

Authors:  Yuya Miura; Ryo Ashida; Teiichi Sugiura; Katsuhisa Ohgi; Mihoko Yamada; Shimpei Otsuka; Akiko Todaka; Katsuhiko Uesaka
Journal:  Surg Case Rep       Date:  2022-01-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.